Peyote as Commodity: An Examination of Market Actors and Access Mechanisms

Feeney, K. | Human Organization | 1 March 2017

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society

Van Hagen, A. G. | BJPsych Bull | 11 August 2016

A Public-Health-Based Vision for the Management and Regulation of Psychedelics

Haden, M., Emerson, B., & Tupper, K. W. | Journal of Psychoactive Drugs | 18 July 2016

Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits

Zhang, M. W., & Ho, R. C. | Ethics & Behavior | 17 May 2016

“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users

Hutton, F., Kivell, B., & Boyle, O. | Journal of Psychoactive Drugs | 13 May 2016

How psychoactive drugs shape human culture: a multi-disciplinary perspective

Wadley, G. | Brain Research Bulletin | 12 April 2016

Meta-analysis of executive functioning in ecstasy/polydrug users

Roberts, C. A., Jones, A., & Montgomery, C. | Psychological medicine | 11 March 2016

Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights.

Walsh, C. | International Journal of Drug Policy | 12 January

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity

Kraehenmann, R., Schmidt, A., Friston, K., Preller, K. H., Seifritz, E., & Vollenweider, F. X. | NeuroImage: Clinical | 22 Aug 2015

Noribogaine is a G-Protein Biased κ-Opioid Receptor Agonist

Maillet, E. L., Milon, N., Heghinian, M. D., Fishback, J., Schürer, S. C., Garamszegi, N., & Mash, D. C. | Neuropharmacology | 21 Aug 2015

5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

Wischhof, L., & Koch, M. | Behavioural pharmacology | 19 Aug 2015

Mathematics and mysticism

Abraham, R. | Progress in biophysics and molecular biology | 14 Aug 2015

Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations

Kometer, M., Pokorny, T., Seifritz, E., & Vollenweider, F. X. | Psychopharmacology | 01 Aug 2015

Antidepressant mechanism of ketamine: perspective from preclinical studies

Scheuing, L., Chiu, C. T., Liao, H. M., & Chuang, D. M. | Frontiers in Neuroscience | 21 July 2015

Psychedelics and creativity: a review of the quantitative literature

Baggott, M. J. | PeerJ PrePrints | 30 June 2015

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., & Nemeroff, C. B. | American Journal of Psychiatry | 29 June 2015

Restructuring consciousness -the psychedelic state in light of integrated information theory

Gallimore, A. R. | Frontiers in Human Neuroscience | 12 June 2015

Protecting the human rights of people who use psychedelics

Krebs, T. S. | The Lancet | 1 April 2015

A brief survey of drug use and other activities preceding mystical-religious experiences

Baggott MJ. | @GitHub | 20 Mar 2015

Does the Nervous System Have an Intrinsic Archaic Language? Entoptic Images and Phosphenes

Sayin, H. U. | Neuroquantology | 2 August 2014

Enhanced repertoire of brain dynamical states during the psychedelic experience

Tagliazucchi, E., Carhart-Harris, R. L., Leech, R., Nutt, D., & Chialvo, D. R. | Human Brain Mapping | 2 July 2014

The Consumption of Psychoactive Plants in Ancient Global and Anatolian Cultures During Religious Rituals: The Roots of the Eruption of Mythological Figures and Common Symbols in Religions and Myths

Sayin, H. U. | NeuroQuantology | 12 June 2014

Psychoactive Plants: A Neglected Area of Ethnobotanical Research in Southern Africa (Review)

Jean-Francois, S. | STUDIES ON ETHNO-MEDICINE | June 2014

Indigenous healing practice: Opening a discussion

Prue, R., & Voss, R. W. | Journal of Pastoral Care & Counseling | June 2014

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

Morris, H., & Wallach, J. | Drug testing and analysis | 26 March 2014

History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS)

Emerson, A., Ponté, L., Jerome, L., & Doblin, R. | Journal of Psychoactive Drugs | 11 March 2014

The Heffter Research Institute: Past and Hopeful Future

Nichols, D. E. | Journal of Psychoactive Drugs | 11 March 2014

From Hofmann to the Haight Ashbury, and into the Future: The Past and Potential of Lysergic Acid Diethlyamide

Smith, D. E., Raswyck, G. E., & Leigh Dickerson Davidson, L. | Journal of Psychoactive Drugs | 11 March 2014

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

Dakwar, E., Anerella, C., Hart, C. L., Levin, F. R., Mathew, S. J., & Nunes, E. V. | Drug and alcohol dependence | 18 Feb 2014

IJTS Special Topic Section: Ketamine ● The Transformative Power of Ketamine: Psychedelic States and a Personal History of Transformation

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ethnographic Accounts of Ketamine Explorations in Psychedelic Culture

Ring, K., Metzner, R., & Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Regarding the Transpersonal Nature of Ketamine Therapy: An Approach to the Work

Becker, J. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Making Ketamine Work in the Long Run

Early, T. S. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ketamine—Its History, Uses, Pharmacology, Therapeutic Practice, and an Exploration of its Potential as a Novel Treatment for Depression

Wolfson, P.E. | The International Journal of Transpersonal Studies | 2014

Phylogenetic inference and trait evolution of the psychedelic mushroom genus Psilocybe sensu lato (Agaricales)

Ramírez-Cruz, V. Guzmán, G., Villalobos-Arámbula, A. R., Rodríguez, A., Matheny, P. B., Sánchez-García, M., & Guzmán-Dávalos, L. | Botany | 6 August 2013

Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet

Kjellgren, A., & Jonsson, K. | Journal of psychoactive drugs | 2 August 2013

Effects of Schedule I drug laws on neuroscience research and treatment innovation

Nutt, D. J., King, L. A., & Nichols, D. E.| Nature Reviews Neuroscience | 12 June 2013

2C or not 2C: phenethylamine designer drug review

Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. | Journal of Medical Toxicology | 9 June 2013

Research on psychedelic substances

Brandt, S. D., & Passie, T. | Drug testing and analysis | 06 Jul 2012

Quantitative Analysis of Narrative Reports of Psychedelic Drugs

Coyle, J. R., Presti, D. E., Baggott, M. J. | 1 June 2012

Drugs as instruments: A new framework for non-addictive psychoactive drug use

Müller, C. P., & Schumann, G.| Behavioral and Brain Sciences | 10 November 2011

Revisiting Wasson’s Soma: Exploring the Effects of Preparation on the Chemistry of Amanita Muscaria

Feeney, K. | Journal of psychoactive drugs | 20 Sep 2011

Psychedelic Experience as a Heuristic Tool for Exploring the Mind and the Brain

Alyushin, A. | NeuroQuantology | September 2011

Ayahuasca, Entheogenic Education & Public Policy

Tupper, K. W. | (Doctoral dissertation, University of British Columbia) | 18 April 2011

Harm potential of magic mushroom use: A review

van Amsterdam, J., Opperhuizen, A., & van den Brink, W. | Regulatory toxicology and pharmacology | 01 April 2011

Ayahuasca, Salutogenesis and the Need for „Ecological“ Approaches

Friczewski, F. | NEIP | 14 November 2010

Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire

Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. | Drug and alcohol dependence | 21 Sep 2010

The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research

Langlitz, N. | History of Human Sciences | February 2010

Effects of varied doses of psilocybin on time interval reproduction in human subjects

Wackermann, J., Wittmann, M., Hasler, F., & Vollenweider, F. X. | Neuroscience letters | 11 Apr 2008

Land of the Living Sky with Diamonds: A Place for Radical Psychiatry?

Dyck, E. | Journal of Canadian Studies | 1 October 2007

Brave New World versus Island — Utopian and Dystopian Views on Psychopharmacology

Schermer, M. H. N. | Medicine, Health Care and Philosophy | 08 May 2007

Hallucinogenic botanicals of America: A growing need for focused drug education and research

Halpern, J. H., & Sewell, R. A. | Life sciences | 22 Dec 2005

Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion

Passie, T., Hartmann, U., Schneider, U., Emrich, H. M., & Krüger, T. H. | Medical hypotheses | 09 Nov 2004